# abrdn Life Sciences Investors: Form SCHEDULE 13D/A, filed Nov 24, 2025

- Company: [abrdn Life Sciences Investors](/companies/hql.md) (CIK 884121)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-24
- Accepted by EDGAR: Nov 24, 2025, 16:36 ET
- Period: not reported
- Accession: 0001062993-25-016997
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/884121/000106299325016997/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884121/000106299325016997/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/884121/000106299325016997/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001062993-25-016997. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.